Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Michael R. Kuffner

Associate

Nashville
(615) 742-7911 TEL
(615) 248-4252 FAX

Michael R. Kuffner

Associate

Nashville
(615) 742-7911 TEL
(615) 248-4252 FAX
Nashville
(615) 742-7911 TEL
(615) 248-4252 FAX

Mike Kuffner focuses his practice on advising clients on transactional, corporate governance and securities law matters. He represents public and private companies, many of whom are engaged in international business activities, across a number of industries including healthcare and technology.

Mike Kuffner focuses his practice on advising clients on transactional, corporate governance and securities law matters. He represents public and private companies, many of whom are engaged in international business activities, across a number of industries including healthcare and technology.

Mike's practice involves assisting on matters related to:

  • Mergers and acquisitions, including cross-border transactions
  • Corporate governance
  • Compliance with securities laws and public company disclosure
  • Capital markets transactions, including initial public offerings, follow-on offerings and shelf takedowns of various types of debt and equity securities
  • Early, seed and follow-on venture capital financing transactions

Mike served as first chair associate on a complex, multi-million dollar acquisition involving international components that resulted in recognition by M&A Advisor for the 2012 M&A Deal of the Year award.

+ Read More

- Read Less

Memberships

American Health Lawyers Association (AHLA)

Bass, Berry & Sims — Entry Level Hiring Committee

News

View More

Representative Experience

View More

Accolades

Mid-South Super Lawyers "Rising Star" (2014-2015)

M&A Advisor Awards "M&A Deal of the Year" (2012)

Alabama Law Review — Senior Editor

Hugo Black Scholar

The University of Alabama, School of Law — Full-academic scholarship

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.